NASDAQ:NVTR - Nasdaq -
0.13
-0.04 (-23.17%)
The current stock price of NVTR is 0.13 null. In the past month the price decreased by -91.72%. In the past year, price decreased by -99.26%.
Nuvectra Corporation develops and commercializes neuromodulation medical device for the treatment of nervous system disorders. It also provides neural interface technology, components and systems, as well as NeuroNexus SmartBox portable control and data streaming systems. Nuvectra Corporation is based in Plano, Texas.
Nuvectra Corporation
5830 GRANITE PKWY SUITE 1100
PLANO TX 75024
CEO: Fred B. Parks
Phone: 214-474-3103
The current stock price of NVTR is 0.13 null. The price decreased by -23.17% in the last trading session.
The exchange symbol of Nuvectra Corporation is NVTR and it is listed on the Nasdaq exchange.
NVTR stock is listed on the Nasdaq exchange.
Nuvectra Corporation (NVTR) has a market capitalization of 2.33M null. This makes NVTR a Nano Cap stock.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NVTR does not pay a dividend.
Nuvectra Corporation (NVTR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.97).
ChartMill assigns a fundamental rating of 4 / 10 to NVTR. The financial health of NVTR is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months NVTR reported a non-GAAP Earnings per Share(EPS) of -2.97. The EPS increased by 16.57% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | -104.27% | ||
ROA | -39.89% | ||
ROE | N/A | ||
Debt/Equity | 0.58 |
ChartMill assigns a Buy % Consensus number of 100% to NVTR. The Buy consensus is the average rating of analysts ratings from 1 analysts.